25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

INAB (In8bio) Stock Analysis
Buy, Hold or Sell?

Let's analyze In8bio together

I guess you are interested in In8bio Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

  • 📊 Fundamental Analysis (FA) – In8bio’s Financial Insights
  • 📈 Technical Analysis (TA) – In8bio’s Price Targets

I'm going to help you getting a better view of In8bio Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about In8bio Inc

I send you an email if I find something interesting about In8bio Inc.

1. Quick Overview

1.1. Quick analysis of In8bio (30 sec.)










1.2. What can you expect buying and holding a share of In8bio? (30 sec.)

How much money do you get?

How much money do you get?
$0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
$4.03
Expected worth in 1 year
$7.65
How sure are you?
43.5%

+ What do you gain per year?

Total Gains per Share
$3.62
Return On Investment
166.2%

For what price can you sell your share?

Current Price per Share
$2.18
Expected price per share
$2.06 - $5.61
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of In8bio (5 min.)




Live pricePrice per Share (EOD)
$2.18
Intrinsic Value Per Share
$-46.78 - $-55.40
Total Value Per Share
$-42.75 - $-51.37

2.2. Growth of In8bio (5 min.)




Is In8bio growing?

Current yearPrevious yearGrowGrow %
How rich?$13.8m$20.5m-$7.8m-62.2%

How much money is In8bio making?

Current yearPrevious yearGrowGrow %
Making money-$6.8m-$7.7m$904.7k13.2%
Net Profit Margin0.0%-50.7%--

How much money comes from the company's main activities?

2.3. Financial Health of In8bio (5 min.)




2.4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  


Richest
#547 / 881

Most Revenue
#858 / 881

Most Profit
#473 / 881

Most Efficient
#336 / 881
3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of In8bio?

Welcome investor! In8bio's management wants to use your money to grow the business. In return you get a share of In8bio.

First you should know what it really means to hold a share of In8bio. And how you can make/lose money.

Speculation

The Price per Share of In8bio is $2.18. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of In8bio.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in In8bio, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $4.03. Based on the TTM, the Book Value Change Per Share is $0.91 per quarter. Based on the YOY, the Book Value Change Per Share is $-0.07 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of In8bio.

How much money are you going to get?

 MRQTTMYOY3Y5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps-1.61-73.9%-1.56-71.8%-0.23-10.4%-0.71-32.5%-0.52-23.8%-0.50-22.8%
Usd Book Value Change Per Share3.83175.7%0.9141.6%-0.07-3.1%0.198.7%0.209.3%0.188.0%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share3.83175.7%0.9141.6%-0.07-3.1%0.198.7%0.209.3%0.188.0%
Usd Price Per Share0.17-0.39-1.29-1.21-1.46-1.27-
Price to Earnings Ratio-0.03--0.22--1.42--1.04--1.21--1.05-
Price-to-Total Gains Ratio0.04-0.00-4.72--3.51--3.63--3.63-
Price to Book Ratio0.04-0.41-2.19-1.49-1.17-1.02-
Price-to-Total Gains Ratio0.04-0.00-4.72--3.51--3.63--3.63-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share2.18
Number of shares458
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share0.910.20
Usd Total Gains Per Share0.910.20
Gains per Quarter (458 shares)414.9792.80
Gains per Year (458 shares)1,659.89371.21
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10166016500371361
20332033100742732
3049804970011141103
4066406630014851474
5082998290018561845
6099599950022272216
701161911610025982587
801327913270029702958
901493914930033413329
1001659916590037123700

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.04.00.00.0%0.012.00.00.0%0.020.00.00.0%0.023.00.00.0%0.023.00.00.0%
Book Value Change Per Share2.02.00.050.0%4.08.00.033.3%8.012.00.040.0%10.013.00.043.5%10.013.00.043.5%
Dividend per Share0.00.04.00.0%0.00.012.00.0%0.00.020.00.0%0.00.023.00.0%0.00.023.00.0%
Total Gains per Share2.02.00.050.0%4.08.00.033.3%8.012.00.040.0%10.013.00.043.5%10.013.00.043.5%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of In8bio Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-3Y+/-5 Year+/-10 Year+/-
Book Value Change Per Share--3.8290.906+323%-0.068+102%0.190+1913%0.203+1790%0.175+2086%
Book Value Per Share--4.0292.669+51%0.607+563%1.457+176%1.409+186%1.226+229%
Current Ratio--4.3033.223+34%4.336-1%4.420-3%6.601-35%5.842-26%
Debt To Asset Ratio--0.3020.367-18%0.291+4%0.3030%0.300+0%0.400-25%
Debt To Equity Ratio--0.4320.597-28%0.412+5%0.452-5%0.658-34%0.763-43%
Dividend Per Share----0%-0%-0%-0%-0%
Enterprise Value--6467742.1807890535.778-18%52030876.040-88%38820120.802-83%51785094.232-88%51785094.232-88%
Eps---1.611-1.565-3%-0.227-86%-0.709-56%-0.519-68%-0.496-69%
Ev To Ebitda Ratio---0.291-0.341+17%-1.791+515%-1.372+371%-2.260+676%-2.260+676%
Free Cash Flow Per Share---0.906-1.126+24%-0.173-81%-0.548-40%-0.405-55%-0.357-61%
Free Cash Flow To Equity Per Share--0.224-0.567+354%0.032+596%-0.256+214%-0.057+126%-0.038+117%
Gross Profit Margin--1.0001.018-2%1.021-2%1.013-1%1.008-1%1.007-1%
Intrinsic Value_10Y_max---55.402----------
Intrinsic Value_10Y_min---46.780----------
Intrinsic Value_1Y_max---2.681----------
Intrinsic Value_1Y_min---2.632----------
Intrinsic Value_3Y_max---10.244----------
Intrinsic Value_3Y_min---9.735----------
Intrinsic Value_5Y_max---20.444----------
Intrinsic Value_5Y_min---18.787----------
Market Cap7508421.400+92%571742.1805761785.778-90%44285876.040-99%31279287.468-98%29416120.674-98%25579235.369-98%
Net Profit Margin----0%-0.5070%-2.0690%-1.2420%-1.0800%
Operating Margin----0%-0.5290%-2.0770%-1.2460%-1.0830%
Operating Ratio----0%0.507-100%2.218-100%1.331-100%1.157-100%
Pb Ratio0.541+92%0.0410.413-90%2.189-98%1.491-97%1.174-96%1.020-96%
Pe Ratio-0.338-1213%-0.026-0.225+773%-1.421+5416%-1.037+3928%-1.213+4610%-1.055+3996%
Price Per Share2.180+92%0.1660.385-57%1.285-87%1.214-86%1.457-89%1.267-87%
Price To Free Cash Flow Ratio-0.601-1213%-0.046-0.337+637%-1.892+4033%-1.219+2562%-1.389+2933%-1.208+2538%
Price To Total Gains Ratio0.569+92%0.043-0.004+109%4.722-99%-3.507+8191%-3.629+8472%-3.629+8472%
Quick Ratio--4.0202.719+48%3.642+10%3.814+5%5.724-30%5.059-21%
Return On Assets---0.279-0.350+25%-0.273-2%-0.288+3%-0.274-2%-0.423+51%
Return On Equity---0.400-0.571+43%-0.388-3%-0.429+7%-0.576+44%-0.792+98%
Total Gains Per Share--3.8290.906+323%-0.068+102%0.190+1913%0.203+1790%0.175+2086%
Usd Book Value--13877000.00012641000.000+10%20505000.000-32%19019666.667-27%19613150.000-29%17045826.087-19%
Usd Book Value Change Per Share--3.8290.906+323%-0.068+102%0.190+1913%0.203+1790%0.175+2086%
Usd Book Value Per Share--4.0292.669+51%0.607+563%1.457+176%1.409+186%1.226+229%
Usd Dividend Per Share----0%-0%-0%-0%-0%
Usd Enterprise Value--6467742.1807890535.778-18%52030876.040-88%38820120.802-83%51785094.232-88%51785094.232-88%
Usd Eps---1.611-1.565-3%-0.227-86%-0.709-56%-0.519-68%-0.496-69%
Usd Free Cash Flow---3122000.000-4846250.000+55%-6015500.000+93%-6194083.333+98%-4915807.650+57%-4345304.783+39%
Usd Free Cash Flow Per Share---0.906-1.126+24%-0.173-81%-0.548-40%-0.405-55%-0.357-61%
Usd Free Cash Flow To Equity Per Share--0.224-0.567+354%0.032+596%-0.256+214%-0.057+126%-0.038+117%
Usd Market Cap7508421.400+92%571742.1805761785.778-90%44285876.040-99%31279287.468-98%29416120.674-98%25579235.369-98%
Usd Price Per Share2.180+92%0.1660.385-57%1.285-87%1.214-86%1.457-89%1.267-87%
Usd Profit---5550000.000-6856250.000+24%-7761000.000+40%-7364166.667+33%-5801700.000+5%-5253217.391-5%
Usd Revenue----0%937000.000-100%339833.333-100%203900.000-100%177304.348-100%
Usd Total Gains Per Share--3.8290.906+323%-0.068+102%0.190+1913%0.203+1790%0.175+2086%
 EOD+6 -2MRQTTM+23 -10YOY+15 -203Y+20 -155Y+17 -1810Y+18 -17

3.3 Fundamental Score

Let's check the fundamental score of In8bio Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-0.338
Price to Book Ratio (EOD)Between0-10.541
Net Profit Margin (MRQ)Greater than00.000
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than14.020
Current Ratio (MRQ)Greater than14.303
Debt to Asset Ratio (MRQ)Less than10.302
Debt to Equity Ratio (MRQ)Less than10.432
Return on Equity (MRQ)Greater than0.15-0.400
Return on Assets (MRQ)Greater than0.05-0.279
Total5/10 (50.0%)

3.4 Technical Score

Let's check the technical score of In8bio Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5030.730
Ma 20Greater thanMa 502.451
Ma 50Greater thanMa 1003.738
Ma 100Greater thanMa 2005.220
OpenGreater thanClose2.120
Total0/5 (0.0%)

4. In-depth Analysis

4.1 About In8bio Inc

IN8bio, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of gamma-delta T cell product candidates for the treatment of cancer and autoimmune diseases. Its products include INB-400, which is in Phase 2 clinical trial to treat newly diagnosed glioblastoma (GBM); INB-200, a genetically modified autologous gamma-delta T cell product candidate that is in Phase I clinical trial for the treatment of GBM; and INB-100, an allogeneic product candidate, which is in Phase I clinical trial to treat patients with hematologic malignancies undergoing hematopoietic stem cell transplantation. The company also develops INB-619, a gamma-delta TCE targeting CD19 for both oncology and autoimmune diseases; INB-300, a nsCAR-enabled DeltEx product candidates targeting difficult liquid tumors and extracranial solid tumors; and INB-500, an induced pluripotent stem cell derived gamma-delta T cells that are in preclinical phase for treatment of cancer. The company was formerly known as Incysus Therapeutics, Inc. and changed its name to IN8bio, Inc. in August 2020. IN8bio, Inc. was incorporated in 2016 and is based in New York, New York.

Fundamental data was last updated by Penke on 2025-06-19 09:13:02.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is cheap.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profit In8bio earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare In8bio to the Biotechnology industry mean.
  • A Net Profit Margin of 0.0% means that $0.00 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of In8bio Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-50.7%+50.7%
TTM-5Y-124.2%+124.2%
5Y-124.2%10Y-108.0%-16.2%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--91.7%+91.7%
TTM--139.0%+139.0%
YOY-50.7%-194.4%+143.7%
3Y-206.9%-248.5%+41.6%
5Y-124.2%-343.3%+219.1%
10Y-108.0%-488.9%+380.9%
4.3.1.2. Return on Assets

Shows how efficient In8bio is using its assets to generate profit.

  • Above 5% is considered healthy but always compare In8bio to the Biotechnology industry mean.
  • -27.9% Return on Assets means that In8bio generated $-0.28 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of In8bio Inc:

  • The MRQ is -27.9%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -35.0%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-27.9%TTM-35.0%+7.1%
TTM-35.0%YOY-27.3%-7.7%
TTM-35.0%5Y-27.4%-7.6%
5Y-27.4%10Y-42.3%+14.9%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-27.9%-11.6%-16.3%
TTM-35.0%-11.7%-23.3%
YOY-27.3%-11.4%-15.9%
3Y-28.8%-11.9%-16.9%
5Y-27.4%-12.1%-15.3%
10Y-42.3%-13.8%-28.5%
4.3.1.3. Return on Equity

Shows how efficient In8bio is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare In8bio to the Biotechnology industry mean.
  • -40.0% Return on Equity means In8bio generated $-0.40 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of In8bio Inc:

  • The MRQ is -40.0%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -57.1%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-40.0%TTM-57.1%+17.1%
TTM-57.1%YOY-38.8%-18.3%
TTM-57.1%5Y-57.6%+0.5%
5Y-57.6%10Y-79.2%+21.7%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-40.0%-13.5%-26.5%
TTM-57.1%-15.0%-42.1%
YOY-38.8%-14.5%-24.3%
3Y-42.9%-16.9%-26.0%
5Y-57.6%-17.9%-39.7%
10Y-79.2%-19.9%-59.3%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of In8bio Inc.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

Measures how efficient In8bio is operating .

  • Measures how much profit In8bio makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare In8bio to the Biotechnology industry mean.
  • An Operating Margin of 0.0% means the company generated $0.00  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of In8bio Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-52.9%+52.9%
TTM-5Y-124.6%+124.6%
5Y-124.6%10Y-108.3%-16.3%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--229.2%+229.2%
TTM--249.7%+249.7%
YOY-52.9%-208.4%+155.5%
3Y-207.7%-221.7%+14.0%
5Y-124.6%-344.1%+219.5%
10Y-108.3%-470.4%+362.1%
4.3.2.2. Operating Ratio

Measures how efficient In8bio is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 0.00 means that the operating costs are $0.00 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of In8bio Inc:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.000
TTM-YOY0.507-0.507
TTM-5Y1.331-1.331
5Y1.33110Y1.157+0.174
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-2.108-2.108
TTM-2.680-2.680
YOY0.5073.080-2.573
3Y2.2183.621-1.403
5Y1.3314.734-3.403
10Y1.1576.546-5.389
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of In8bio Inc.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if In8bio is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 4.30 means the company has $4.30 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of In8bio Inc:

  • The MRQ is 4.303. The company is very able to pay all its short-term debts. +2
  • The TTM is 3.223. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ4.303TTM3.223+1.080
TTM3.223YOY4.336-1.113
TTM3.2235Y6.601-3.378
5Y6.60110Y5.842+0.758
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ4.3033.659+0.644
TTM3.2233.834-0.611
YOY4.3364.141+0.195
3Y4.4204.661-0.241
5Y6.6015.756+0.845
10Y5.8426.151-0.309
4.4.3.2. Quick Ratio

Measures if In8bio is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare In8bio to the Biotechnology industry mean.
  • A Quick Ratio of 4.02 means the company can pay off $4.02 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of In8bio Inc:

  • The MRQ is 4.020. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 2.719. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ4.020TTM2.719+1.302
TTM2.719YOY3.642-0.924
TTM2.7195Y5.724-3.005
5Y5.72410Y5.059+0.665
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ4.0202.799+1.221
TTM2.7193.143-0.424
YOY3.6423.794-0.152
3Y3.8144.307-0.493
5Y5.7245.707+0.017
10Y5.0596.457-1.398
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of In8bio Inc.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much % of In8bio assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare In8bio to Biotechnology industry mean.
  • A Debt to Asset Ratio of 0.30 means that In8bio assets are financed with 30.2% credit (debt) and the remaining percentage (100% - 30.2%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of In8bio Inc:

  • The MRQ is 0.302. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.367. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.302TTM0.367-0.065
TTM0.367YOY0.291+0.076
TTM0.3675Y0.300+0.066
5Y0.30010Y0.400-0.099
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.3020.324-0.022
TTM0.3670.347+0.020
YOY0.2910.329-0.038
3Y0.3030.340-0.037
5Y0.3000.349-0.049
10Y0.4000.379+0.021
4.5.4.2. Debt to Equity Ratio

Measures if In8bio is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare In8bio to the Biotechnology industry mean.
  • A Debt to Equity ratio of 43.2% means that company has $0.43 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of In8bio Inc:

  • The MRQ is 0.432. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.597. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.432TTM0.597-0.165
TTM0.597YOY0.412+0.185
TTM0.5975Y0.658-0.060
5Y0.65810Y0.763-0.105
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.4320.379+0.053
TTM0.5970.435+0.162
YOY0.4120.412+0.000
3Y0.4520.446+0.006
5Y0.6580.460+0.198
10Y0.7630.509+0.254
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings In8bio generates.

  • Above 15 is considered overpriced but always compare In8bio to the Biotechnology industry mean.
  • A PE ratio of -0.03 means the investor is paying $-0.03 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of In8bio Inc:

  • The EOD is -0.338. Based on the earnings, the company is expensive. -2
  • The MRQ is -0.026. Based on the earnings, the company is expensive. -2
  • The TTM is -0.225. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-0.338MRQ-0.026-0.312
MRQ-0.026TTM-0.225+0.199
TTM-0.225YOY-1.421+1.196
TTM-0.2255Y-1.213+0.988
5Y-1.21310Y-1.055-0.158
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-0.338-2.282+1.944
MRQ-0.026-2.062+2.036
TTM-0.225-2.541+2.316
YOY-1.421-3.722+2.301
3Y-1.037-3.754+2.717
5Y-1.213-6.100+4.887
10Y-1.055-6.653+5.598
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of In8bio Inc:

  • The EOD is -0.601. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -0.046. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -0.337. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-0.601MRQ-0.046-0.555
MRQ-0.046TTM-0.337+0.292
TTM-0.337YOY-1.892+1.555
TTM-0.3375Y-1.389+1.051
5Y-1.38910Y-1.208-0.181
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-0.601-3.101+2.500
MRQ-0.046-2.689+2.643
TTM-0.337-3.594+3.257
YOY-1.892-4.363+2.471
3Y-1.219-5.065+3.846
5Y-1.389-8.478+7.089
10Y-1.208-9.273+8.065
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price of In8bio is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of 0.04 means the investor is paying $0.04 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of In8bio Inc:

  • The EOD is 0.541. Based on the equity, the company is cheap. +2
  • The MRQ is 0.041. Based on the equity, the company is cheap. +2
  • The TTM is 0.413. Based on the equity, the company is cheap. +2
Trends
Current periodCompared to+/- 
EOD0.541MRQ0.041+0.500
MRQ0.041TTM0.413-0.371
TTM0.413YOY2.189-1.776
TTM0.4135Y1.174-0.761
5Y1.17410Y1.020+0.153
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD0.5411.932-1.391
MRQ0.0411.848-1.807
TTM0.4132.119-1.706
YOY2.1892.469-0.280
3Y1.4912.526-1.035
5Y1.1743.667-2.493
10Y1.0204.351-3.331
4.6.2. Total Gains per Share

4.7 Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of In8bio Inc.

4.8.1. Institutions holding In8bio Inc

Institutions are holding 20.981% of the shares of In8bio Inc.

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2025-03-31BIOS CAPITAL MANAGEMENT, LP9.47421.803860000100
2025-03-31Franklin Resources Inc6.27520.0003569620200
2025-03-31Alyeska Investment Group, L.P.2.2910.00142079575-2983716-58.9284
2025-03-31Vanguard Group Inc1.98620180295637905926.6212
2025-03-31AIGH Capital Management, LLC1.59740.09971450000-4741865-76.5822
2025-03-31Sigma Planning Corp0.77190.0037700680-340700-32.7162
2025-03-31Geode Capital Management, LLC0.626405686315343810.3724
2025-03-31Northern Trust Corp0.102909342000
2025-03-31State Street Corp0.097808874600
2025-03-31XTX Topco Ltd0.07680.0006697082730964.4095
2025-03-31Chicago Partners Investment Group LLC0.07630.000469301693010
2024-12-31UBS Group AG0.064805885332583124.0312
2025-03-31BlackRock Inc0.0645058504-1068-1.7928
2025-03-31TWO SIGMA SECURITIES, LLC0.03780.000934279342790
2025-03-31Overbrook Management Corp0.03720.00133375600
2025-03-31Citadel Advisors Llc0.0324029450294500
2025-03-31Susquehanna International Group, LLP0.0273024812248120
2025-03-31Tower Research Capital LLC0.02240.00012029217179.2436
2025-03-31Capital Investment Advisory Services, LLC0.01940.000317605176050
2025-03-31Virtu Financial LLC0.01660.000215110-6880-31.2869
Total 23.69851.911921511881-7404676-34.4%

4.9.2. Funds holding In8bio Inc

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2025-05-31Franklin Biotechnology Discv A(acc)USD3.97260.0427360600200
2025-04-30Franklin Biotechnology Discovery A2.30270.0499209020000
2025-04-30Vanguard Total Stock Mkt Idx Inv1.0493095248700
2025-04-30Vanguard Institutional Extnd Mkt Idx Tr0.93690.000185046900
2025-04-30Fidelity Extended Market Index0.3510.0002318618-3045-0.9466
2025-04-30Fidelity Series Total Market Index0.085807785700
2025-04-30Spartan Extended Market Index Pool F0.07670.00026963530454.5728
2025-03-31Northern Trust Extended Eq Market Idx0.06990.00016341500
2025-03-31NT Ext Equity Mkt Idx Fd - L0.06990.00016341500
2025-04-30Fidelity Total Market Index0.067506122800
2025-05-31iShares Micro-Cap ETF0.05090.00094621400
2025-03-31NT Ext Equity Mkt Idx Fd - NL0.03130.00012843500
2025-03-31NT Ext Equity Mkt Idx Fd - DC - NL - T20.02440.000122135-403-1.7881
2025-04-30Spartan Total Market Index Pool G0.0222020163768961.6402
2025-04-30Fidelity Nasdaq Composite Index0.0188017031-11633-40.584
2025-03-31NT Ext Eq Mkt Indx Fd DC Lending Tier 50.01680.0001152301190.7875
2024-12-31NT Ext Eq Mkt Indx Fd DC Lend T30.01660.000215110151100
2024-12-31NT Ext Eq Mkt Indx Fd DC Lend T40.01660.000215110151100
2025-05-31State St US Extended Mkt Indx NL Cl C0.01440.00011310000
2025-04-301290 VT Micro Cap K0.00530.0006477800
Total 9.19960.09568350632+25992+0.3%

5.3. Insider Transactions

Insiders are holding 4.2% of the shares of In8bio Inc.

DateOwnerTypeAmountPricePost Transaction AmountLink
2023-09-13Jeremy R GraffBUY8328.5
2023-08-25Patrick MccallBUY3330.9
2023-08-24William Tai-wei HoBUY79331.5
2022-08-16Emily FairbairnBUY2631557
2022-08-16Kate RochlinBUY17557
2022-08-16Lawrence LambBUY1757
2022-08-16Trishna GoswamiBUY8757
2022-08-16William Tai-wei HoBUY87757
3rd party ad coffee SUPPORTERis ad-free.

5. Financial Statements




5.1. Latest Balance Sheet

Balance Sheet of 2025-03-31. Currency in USD. All numbers in thousands.

Summary
Total Assets19,869
Total Liabilities5,992
Total Stockholder Equity13,877
 As reported
Total Liabilities 5,992
Total Stockholder Equity+ 13,877
Total Assets = 19,869

Assets

Total Assets19,869
Total Current Assets12,725
Long-term Assets7,144
Total Current Assets
Cash And Cash Equivalents 11,888
Other Current Assets 837
Total Current Assets  (as reported)12,725
Total Current Assets  (calculated)12,725
+/-0
Long-term Assets
Property Plant Equipment 6,600
Long-term Assets Other 544
Long-term Assets  (as reported)7,144
Long-term Assets  (calculated)7,144
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities2,957
Long-term Liabilities3,035
Total Stockholder Equity13,877
Total Current Liabilities
Short-term Debt 1,237
Accounts payable 575
Other Current Liabilities 570
Total Current Liabilities  (as reported)2,957
Total Current Liabilities  (calculated)2,382
+/- 575
Long-term Liabilities
Capital Lease Obligations Min Short Term Debt3,035
Long-term Liabilities  (as reported)3,035
Long-term Liabilities  (calculated)3,035
+/-0
Total Stockholder Equity
Common Stock8
Retained Earnings -127,206
Other Stockholders Equity 141,075
Total Stockholder Equity (as reported)13,877
Total Stockholder Equity (calculated)13,877
+/-0
Other
Capital Stock8
Cash and Short Term Investments 11,888
Common Stock Shares Outstanding 2,783
Liabilities and Stockholders Equity 19,869
Net Debt -7,616
Net Invested Capital 13,877
Net Working Capital 9,768
Property Plant and Equipment Gross 9,119
Short Long Term Debt Total 4,272



5.2. Balance Sheets Structured

Currency in USD. All numbers in thousands.

 Trend2025-03-312024-12-312024-09-302024-06-302024-03-312023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-06-302018-03-312017-12-31
> Total Assets 
0
0
0
0
0
0
1,130
1,130
0
3,647
0
20,910
20,423
17,564
47,134
42,223
36,538
30,988
38,383
33,039
24,678
29,718
26,208
33,709
25,549
22,496
15,966
20,944
19,869
19,86920,94415,96622,49625,54933,70926,20829,71824,67833,03938,38330,98836,53842,22347,13417,56420,42320,91003,64701,1301,130000000
   > Total Current Assets 
0
0
0
0
0
0
763
763
610
3,325
18,144
18,144
15,372
12,167
43,877
38,980
33,274
26,999
29,654
22,234
14,402
19,465
16,549
24,625
15,755
12,682
6,703
12,578
12,725
12,72512,5786,70312,68215,75524,62516,54919,46514,40222,23429,65426,99933,27438,98043,87712,16715,37218,14418,1443,325610763763000000
       Cash And Cash Equivalents 
0
0
0
0
0
0
610
610
-610
3,180
0
17,994
15,052
11,999
40,675
37,021
32,107
25,742
27,647
18,182
10,860
16,993
12,854
21,282
13,015
10,217
4,001
11,120
11,888
11,88811,1204,00110,21713,01521,28212,85416,99310,86018,18227,64725,74232,10737,02140,67511,99915,05217,99403,180-610610610000000
       Short-term Investments 
0
0
0
0
0
0
0
0
1,220
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000000001,22000000000
       Other Current Assets 
0
0
0
0
0
0
153
153
0
145
0
150
320
168
3,202
1,959
2,334
2,514
4,004
4,052
3,542
2,472
3,695
3,343
2,740
2,465
2,702
1,458
837
8371,4582,7022,4652,7403,3433,6952,4723,5424,0524,0042,5142,3341,9593,20216832015001450153153000000
   > Long-term Assets 
0
0
0
0
0
0
367
367
-610
322
0
2,766
5,051
5,397
3,257
3,243
3,264
3,989
8,729
10,805
10,276
10,253
9,659
9,084
9,794
9,814
9,263
9,409
7,144
7,1449,4099,2639,8149,7949,0849,65910,25310,27610,8058,7293,9893,2643,2433,2575,3975,0512,7660322-610367367000000
       Property Plant Equipment 
0
0
0
0
0
0
274
274
0
230
186
186
1,776
1,894
2,848
2,834
2,855
3,491
8,120
10,172
9,768
9,745
9,150
8,573
9,218
9,235
8,499
7,825
6,600
6,6007,8258,4999,2359,2188,5739,1509,7459,76810,1728,1203,4912,8552,8342,8481,8941,7761861862300274274000000
       Goodwill 
0
0
0
0
0
0
0
0
0
0
0
0
0
3,362
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000003,3620000000000000
       Intangible Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
126
126
0
0
0
0
0
0
0
0
0
000000000126126000000000000000000
       Other Assets 
0
0
0
0
0
0
0
0
0
0
2,580
2,580
3,275
3,503
409
409
409
498
483
0
0
508
0
0
0
0
0
-1,043
0
0-1,04300000508004834984094094093,5033,2752,5802,5800000000000
> Total Liabilities 
0
0
0
0
0
0
647
1,476
0
2,812
0
2,589
4,104
3,903
4,096
4,040
3,703
4,420
8,819
10,307
7,890
7,919
8,450
8,772
8,023
8,875
7,378
6,466
5,992
5,9926,4667,3788,8758,0238,7728,4507,9197,89010,3078,8194,4203,7034,0404,0963,9034,1042,58902,81201,476647000000
   > Total Current Liabilities 
0
0
0
0
0
0
647
647
0
1,867
2,572
2,572
3,062
2,773
2,160
2,256
2,068
2,972
4,900
5,822
3,748
3,781
4,686
5,393
3,844
4,759
3,635
3,083
2,957
2,9573,0833,6354,7593,8445,3934,6863,7813,7485,8224,9002,9722,0682,2562,1602,7733,0622,5722,5721,8670647647000000
       Short-term Debt 
0
0
0
0
0
0
0
0
0
58
0
174
770
826
1,256
626
1,262
1,120
1,830
2,778
1,386
3,044
2,996
3,028
1,536
3,564
1,729
1,647
1,237
1,2371,6471,7293,5641,5363,0282,9963,0441,3862,7781,8301,1201,2626261,256826770174058000000000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
58
0
174
174
174
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000174174174058000000000
       Accounts payable 
0
0
0
0
0
0
560
560
0
561
620
620
660
462
692
395
553
887
1,108
2,091
870
585
748
924
1,413
1,444
1,137
389
575
5753891,1371,4441,4139247485858702,0911,1088875533956924626606206205610560560000000
       Other Current Liabilities 
0
0
0
0
0
0
87
87
0
1,248
876
1,778
1,632
1,485
212
1,235
253
965
1,962
953
1,492
152
942
1,441
895
-249
769
1,047
570
5701,047769-2498951,4419421521,4929531,9629652531,2352121,4851,6321,7788761,24808787000000
   > Long-term Liabilities 
0
0
0
0
0
0
0
829
0
945
0
17
1,042
1,130
1,936
1,784
1,635
1,448
3,919
4,485
4,142
4,138
3,764
3,379
4,179
4,116
3,743
3,383
3,035
3,0353,3833,7434,1164,1793,3793,7644,1384,1424,4853,9191,4481,6351,7841,9361,1301,04217094508290000000
       Warrants
0
0
0
0
0
0
0
0
0
0
0
0
0
34,900
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000034,9000000000000000
       Other Liabilities 
0
0
0
0
0
0
0
0
0
0
17
17
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000000017170000000000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
0
0
0
2,439
2,439
3,134
3,362
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000003,3623,1342,4392,4390000000000
> Total Stockholder Equity
0
0
0
0
0
0
483
-346
483
835
0
18,321
16,319
13,661
43,038
38,183
32,835
26,568
29,564
22,732
16,788
21,799
17,758
24,937
17,526
13,621
8,588
14,478
13,877
13,87714,4788,58813,62117,52624,93717,75821,79916,78822,73229,56426,56832,83538,18343,03813,66116,31918,3210835483-346483000000
   Common Stock
0
0
0
0
0
0
1
1
0
1
1
1
1
1
3
2
2
2
3
3
3
4
4
4
4
5
5
7
8
87554444333222311111011000000
   Retained Earnings Total Equity0000000-76,452-68,73700000-26,842-23,4510000000000000
   Accumulated Other Comprehensive Income 00000000000000-47,1340-27900-213-9,242-1690000000
   Capital Surplus 
0
0
0
0
0
0
0
0
0
0
0
0
0
2,211
69,877
0
0
0
0
0
85,522
98,247
0
0
0
0
0
0
0
000000098,24785,5220000069,8772,2110000000000000
   Treasury Stock00000000000000000000000000000
   Other Stockholders Equity 
0
0
0
0
0
0
238
238
0
523
0
1,458
1,819
2,211
69,877
70,872
71,669
72,581
82,975
83,941
85,522
98,247
101,375
116,152
117,303
122,026
124,079
136,127
141,075
141,075136,127124,079122,026117,303116,152101,37598,24785,52283,94182,97572,58171,66970,87269,8772,2111,8191,45805230238238000000



5.3. Balance Sheets

Currency in USD. All numbers in thousands.




5.4. Cash Flows

Currency in USD. All numbers in thousands.




5.5. Income Statements

Currency in USD. All numbers in thousands.


5.6. Latest Income Statement

Income Statement (annual), 2024-12-31. Currency in USD. All numbers in thousands.

Gross Profit (+$)
totalRevenue0
Cost of Revenue-0
Gross Profit00
 
Operating Income (+$)
Gross Profit0
Operating Expense-30,667
Operating Income-30,437-30,667
 
Operating Expense (+$)
Research Development16,962
Selling General Administrative12,637
Selling And Marketing Expenses0
Operating Expense30,66729,599
 
Net Interest Income (+$)
Interest Income230
Interest Expense-0
Other Finance Cost-0
Net Interest Income230
 
Pretax Income (+$)
Operating Income-30,437
Net Interest Income230
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-30,437-29,369
EBIT - interestExpense = -30,437
-30,437
-30,437
Interest Expense0
Earnings Before Interest and Taxes (EBIT)-30,437-30,437
Earnings Before Interest and Taxes (EBITDA)-27,782
 
After tax Income (+$)
Income Before Tax-30,437
Tax Provision-0
Net Income From Continuing Ops-30,437-30,437
Net Income-30,437
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses0
Total Other Income/Expenses Net-1,068-230
 

Technical Analysis of In8bio
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of In8bio. The general trend of In8bio is BEARISH with 100.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine In8bio's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-100.0%) Bearish trend (100.0%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. In8bio Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of In8bio Inc.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is -1/(-1 +1).

  • Around resistance: The price is trading arround resistance levels. This can be considered as a potential exit level. -1

The bullish price targets are: 2.3 < 2.3 < 5.61.

The bearish price targets are: 2.06.

Know someone who trades $INAB? Share this with them.👇

In8bio Inc Daily Support & Resistance Chart
3rd party ad coffee SUPPORTERis ad-free.

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of In8bio Inc. The current mas is .

The long score for the Moving Averages is 0/14.
The longshort score for the Moving Averages is -14/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

In8bio Inc Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of In8bio Inc. The current macd is -0.48344456.

The long score for the Moving Average Convergence/Divergence (MACD) is 3/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 2/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the In8bio price going up in the near term. +2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for In8bio. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the In8bio price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
In8bio Inc Daily Moving Average Convergence/Divergence (MACD) ChartIn8bio Inc Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of In8bio Inc. The current adx is 33.55.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -3/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell In8bio shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX > 25 && ADX trending down: The ADX is above 25 and indicates a strong bearish trend. The ADX is declining, the bearish trend is weakening. Could be a potential reversal to the upside. -2
In8bio Inc Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of In8bio Inc. The current sar is 2.05.

The long score for the Parabolic SAR is 1/1.
The longshort score for the Parabolic SAR is 1/(-1 +1).

  • Close > SAR: The price is above the SAR. It's generally considered a bullish signal. +1
In8bio Inc Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of In8bio Inc. The current rsi is 30.73. The current phase is Continuation in bear market.

The long score for the Relative Strength Index (RSI) is 1/13.
The longshort score for the Relative Strength Index (RSI) is -2/(-13 +13).

  • Continuation in bear market: Downtrend continues after a consolidation or pullback. Hold or add to short positions.
  • Trending up: The RSI is trending up. +1
In8bio Inc Daily Relative Strength Index (RSI) ChartIn8bio Inc Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of In8bio Inc. The current phase is Continuation in bear market.

The long score for the Stochastic Oscillator is 3/6.
The longshort score for the Stochastic Oscillator is 2/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the In8bio price going up in the near term. +2
  • Trending up: The STOCH %K is trending up. +1
In8bio Inc Daily Stochastic Oscillator ChartIn8bio Inc Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of In8bio Inc. The current cci is -43.43368332.

In8bio Inc Daily Commodity Channel Index (CCI) ChartIn8bio Inc Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of In8bio Inc. The current cmo is -35.21534936.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
In8bio Inc Daily Chande Momentum Oscillator (CMO) ChartIn8bio Inc Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of In8bio Inc. The current willr is -57.37704918.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that In8bio is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
In8bio Inc Daily Williams %R ChartIn8bio Inc Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of In8bio Inc.

In8bio Inc Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of In8bio Inc. The current atr is 0.28628292.

In8bio Inc Daily Average True Range (ATR) ChartIn8bio Inc Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of In8bio Inc. The current obv is 2,012,986.

In8bio Inc Daily On-Balance Volume (OBV) ChartIn8bio Inc Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of In8bio Inc. The current mfi is 40.69.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -1/(-2 +2).

  • MFI < 50: -1
In8bio Inc Daily Money Flow Index (MFI) ChartIn8bio Inc Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for In8bio Inc.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2025-02-11STOCH LONG EXITThe %K line crosses below the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2025-02-13STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2025-02-14STOCH LONG EXITThe %K line crosses below the %D line.
2025-02-18CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-02-19STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-02-21STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-02-24WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-02-25MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2025-02-26STOCH SHORT EXITThe %K line crosses above the %D line.
2025-02-27STOCH LONG EXITThe %K line crosses below the %D line.
2025-02-28STOCH SHORT EXITThe %K line crosses above the %D line.
2025-03-03STOCH LONG EXITThe %K line crosses below the %D line.
2025-03-04STOCH SHORT EXITThe %K line crosses above the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-03-06STOCH LONG EXITThe %K line crosses below the %D line.
2025-03-07CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-03-11DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-03-13STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-03-17STOCH SHORT EXITThe %K line crosses above the %D line.
2025-03-24STOCH LONG EXITThe %K line crosses below the %D line.
2025-03-25CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-03-26STOCH SHORT EXITThe %K line crosses above the %D line.
2025-03-28STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-04-01STOCH SHORT EXITThe %K line crosses above the %D line.
2025-04-03STOCH LONG EXITThe %K line crosses below the %D line.
2025-04-04STOCH SHORT EXITThe %K line crosses above the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2025-04-10STOCH LONG EXITThe %K line crosses below the %D line.
2025-04-11STOCH SHORT EXITThe %K line crosses above the %D line.
2025-04-14RSI LONG ENTRY SHORT CLOSE30 crossover to upside
2025-04-15MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2025-04-16STOCH LONG EXITThe %K line crosses below the %D line.
2025-04-17STOCH SHORT EXITThe %K line crosses above the %D line.
2025-04-22CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-04-23DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2025-04-24STOCH LONG EXITThe %K line crosses below the %D line.
2025-04-25STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2025-04-28STOCH LONG EXITThe %K line crosses below the %D line.
2025-04-29DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-05-08STOCH SHORT EXITThe %K line crosses above the %D line.
2025-05-09STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-05-12STOCH SHORT EXITThe %K line crosses above the %D line.
2025-05-13WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-05-14MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2025-05-15STOCH SHORT EXITThe %K line crosses above the %D line.
2025-05-19STOCH LONG EXITThe %K line crosses below the %D line.
2025-05-20RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2025-05-21STOCH LONG EXITThe %K line crosses below the %D line.
2025-05-22RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
2025-05-27MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2025-05-28DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
2025-05-29DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-05-30STOCH LONG EXITThe %K line crosses below the %D line.
2025-06-02CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2025-06-03DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-06-04MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-06-05MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2025-06-06MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-06-09MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-06-12MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2025-06-16STOCH SHORT EXITThe %K line crosses above the %D line.
2025-06-17STOCH LONG EXITThe %K line crosses below the %D line.
2025-06-18STOCH SHORT EXITThe %K line crosses above the %D line.
2025-06-23MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2025-06-25STOCH LONG EXITThe %K line crosses below the %D line.
2025-06-27MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2025-07-01MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2025-07-02STOCH SHORT EXITThe %K line crosses above the %D line.
2025-07-03SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
RSI LONG ENTRY SHORT CLOSE30 crossover to upside

6.3. Candlestick Patterns

In8bio Inc Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of In8bio Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5030.730
Ma 20Greater thanMa 502.451
Ma 50Greater thanMa 1003.738
Ma 100Greater thanMa 2005.220
OpenGreater thanClose2.120
Total0/5 (0.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of In8bio with someone you think should read this too:
  • Are you bullish or bearish on In8bio? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about In8bio? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about In8bio Inc

I send you an email if I find something interesting about In8bio Inc.


Comments

How you think about this?

Leave a comment

Stay informed about In8bio Inc.

Receive notifications about In8bio Inc in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.